Gevorg Grigoryan

Title: Gevorg Grigoryan: Innovator in Cancer Treatment

Introduction

Gevorg Grigoryan is a notable inventor based in Hanover, NH (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of peptides. His work focuses on the selective targeting of Bcl-2 family proteins, which play a crucial role in regulating cell death.

Latest Patents

Gevorg Grigoryan holds a patent for "Peptides selective for Bcl-2 family proteins." This patent includes peptides that are selective for combinations of Mcl-1, Bfl-, and Bcl-xL. The patent also describes compositions containing these polypeptides and methods for using them in cancer treatment, specifically through the administration of these peptides to a subject.

Career Highlights

Throughout his career, Gevorg has worked with prestigious institutions such as the Massachusetts Institute of Technology and Dartmouth College. His experience in these renowned organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Gevorg has collaborated with notable individuals in his field, including Vincent Xue and Justin Michael Jenson. These collaborations have further enriched his research and development efforts.

Conclusion

Gevorg Grigoryan is a dedicated inventor whose work in peptide development for cancer treatment showcases his commitment to advancing medical science. His innovative approach and collaborations highlight the importance of teamwork in achieving breakthroughs in healthcare.